Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Diagnos Laboratorium Utama Tbk. (DGNS) vs Reksa Dana Majoris Government Bonds ETF Indonesia (XMGB) Price & Performance

Diagnos Laboratorium Utama Tbk.Trade
Reksa Dana Majoris Government Bonds ETF IndonesiaTrade

Price performance (Past 24H)

Key statistics

Diagnos Laboratorium Utama Tbk. vs Reksa Dana Majoris Government Bonds ETF Indonesia — how do they compare? Diagnos Laboratorium Utama Tbk. trades at Rp224 (market cap 308B), while Reksa Dana Majoris Government Bonds ETF Indonesia trades at Rp1,118 (market cap 116.27B). The key difference: Diagnos Laboratorium Utama Tbk. is far larger — about 2.6× Reksa Dana Majoris Government Bonds ETF Indonesia's market cap. Which is the better fit depends on your goals.

DGNSXMGB
Market Cap
308B116.27B
Indicative Equilibrium Price
230
Indicative Equilibrium Volume
100

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

DGNS
View details

About Diagnos Laboratorium Utama Tbk.

PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.

Read more on DGNS

About Reksa Dana Majoris Government Bonds ETF Indonesia

Read more on XMGB